Goodman Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Buy
642,252
+21,038
+3% +$560K 3.1% 7
2025
Q4
$15.5M Buy
621,214
+137,772
+28% +$3.47M 2.93% 14
2025
Q3
$12.3M Buy
483,442
+9,442
+2% +$233K 2.4% 22
2025
Q2
$11.5M Buy
474,000
+29,398
+7% +$686K 2.31% 26
2025
Q1
$11.3M Buy
444,602
+12,331
+3% +$323K 2.43% 26
2024
Q4
$11.5M Buy
432,271
+22,609
+6% +$613K 2.45% 27
2024
Q3
$11.9M Buy
409,662
+15,981
+4% +$466K 2.65% 24
2024
Q2
$11M Buy
393,681
+45,326
+13% +$1.25M 2.45% 24
2024
Q1
$9.67M Buy
348,355
+78,649
+29% +$2.18M 2.21% 29
2023
Q4
$7.76M Buy
269,706
+11,826
+5% +$357K 2.08% 28
2023
Q3
$8.55M Buy
257,880
+15,476
+6% +$547K 2.5% 27
2023
Q2
$8.89M Buy
242,404
+7,522
+3% +$293K 2.46% 27
2023
Q1
$9.58M Buy
+234,882
New +$10.1M 2.78% 22
2018
Q1
Sell
-820
Closed -$28K 110
2017
Q4
$28K Buy
+820
New +$28K 0.01% 105

Other funds holding PFE

Goodman Financial's PFE Position: Q1 2026 in Review

Goodman Financial increased its Pfizer (PFE) stake by 3.4% in Q1 2026, buying an estimated $560K and bringing the position to 642,252 shares worth $18M. The position accounts for 3.1% of the portfolio, ranked #7.

Goodman Financial first reported a position in PFE in Q4 2017 and has held it in 14 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Goodman Financial held 642,252 shares of Pfizer worth $18M as of Q1 2026.
  • Goodman Financial bought 21,038 Pfizer shares in Q1 2026, an estimated $560K.
  • Pfizer made up 3.1% of Goodman Financial's portfolio in Q1 2026, its #7 holding.
  • Goodman Financial first reported a position in Pfizer in Q4 2017 and has held it in 14 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Goodman Financial's 13F filing for Q1 2026, filed 6 May 2026.